TrialLancet (London, England)2023

Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.

Roberto Diletti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.